Related Experiment Video
Updated: Apr 14, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Refractory polymyositis undergoing remission following antitubercular therapy
Durga Prasanna Misra1, Sukesh Edavalath1, Abhra Chandra Chowdhury1
1Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Treating an opportunistic infection, miliary tuberculosis, led to remission in a polymyositis patient. This case highlights the intricate link between autoimmune conditions and the body's response to infection.
Area of Science:
- Immunology
- Infectious Diseases
- Rheumatology
Background:
- Immunosuppressive therapy is crucial for managing autoimmune diseases but increases opportunistic infection risk.
- Polymyositis, an autoimmune condition, often requires intensive immunosuppression, potentially compromising host defense.
- Miliary tuberculosis is a severe disseminated form of tuberculosis, particularly concerning in immunocompromised individuals.
Observation:
- A woman with polymyositis refractory to high-dose steroids and methotrexate developed miliary tuberculosis.
- The patient's polymyositis showed remission following antitubercular therapy, even with reduced immunosuppression intensity.
Findings:
- This is the first reported case where myositis achieved remission by treating an intercurrent infection.
- Antitubercular therapy was effective in resolving the autoimmune myositis symptoms.
Implications:
- Treating infections may offer a therapeutic strategy for certain autoimmune disease flares.
- The complex interplay between autoimmune disease activity and infection warrants further investigation.
- This case underscores the importance of considering and managing infections in immunosuppressed patients with autoimmune diseases.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
